SARS-CoV-2 variant B.1.1.7 is susceptible to neutralizing antibodies elicited by ancestral spike vaccines-Reference-Cited by-同舟云学术

SARS-CoV-2 variant B.1.1.7 is susceptible to neutralizing antibodies elicited by ancestral spike vaccines

Published:2021-04 Issue:4 Volume:29 Page:529-539.e3
ISSN:1931-3128
Container-title:Cell Host & Microbe
language:en
Short-container-title:Cell Host & Microbe

Author:

Shen Xiaoying,Tang Haili,McDanal Charlene,Wagh Kshitij,Fischer William,Theiler James,Yoon Hyejin,Li Dapeng,Haynes Barton F.,Sanders Kevin O.,Gnanakaran Sandrasegaram,Hengartner Nick,Pajon Rolando,Smith Gale,Glenn Gregory M.,Korber Bette,Montefiori David C.

Funder

National Institutes of Health

Publisher

Elsevier BV

Subject

Virology,Microbiology,Parasitology

Reference54 articles.

1. Safety and Immunogenicity of SARS-CoV-2 mRNA-1273 Vaccine in Older Adults;Anderson;N. Engl. J. Med.,2020

2. Efficacy and Safety of the mRNA-1273 SARS-CoV-2 Vaccine;Baden;N. Engl. J. Med.,2020

3. SARS-CoV-2 neutralizing antibody structures inform therapeutic strategies;Barnes;Nature,2020

4. Antibody cocktail to SARS-CoV-2 spike protein prevents rapid mutational escape seen with individual antibodies;Baum;Science,2020

5. Analysis of RNA sequences of 3636 SARS-CoV-2 collected from 55 countries reveals selective sweep of one virus type;Biswas;Indian J. Med. Res.,2020

Cited by 294 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. COVID-19 mutations: An overview;World Journal of Methodology;2024-09-20

2. A review of the immunogenicity and safety of booster doses of omicron variant-containing mRNA-1273 COVID-19 vaccines in adults and children;Expert Review of Vaccines;2024-09-09

3. A review: evaluating methods for analyzing kidney stones and investigating the influence of major and trace elements on their formation;Reviews in Inorganic Chemistry;2024-08-28

4. SARS-CoV-2 recombinant spike ferritin nanoparticle vaccine adjuvanted with Army Liposome Formulation containing monophosphoryl lipid A and QS-21: a phase 1, randomised, double-blind, placebo-controlled, first-in-human clinical trial;The Lancet Microbe;2024-06

5. SARS-CoV-2 Neutralization Assays Used in Clinical Trials: A Narrative Review;Vaccines;2024-05-18